Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Change of Auditor
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that following the conclusion of a tender process overseen by the Company's Audit Committee, the Company has appointed Crowe U.K. LLP ("Crowe U.K.") as the Company's independent auditor with effect from 25 November 2025.
Crowe U.K. will conduct the audit of the Company's financial statements for the financial period to 31 January 2026 and any proposal to re-appoint Crowe U.K. as auditors of the Company will be subject to the approval of shareholders at the 2026 Annual General Meeting.
BDO LLP, the Company's outgoing independent auditor, has confirmed that there are no matters connected with their ceasing to hold office that need to be brought to the attention of the members or creditors of the Company for the purposes of section 519 of the Companies Act 2006.
Enquiries:
| Inspiration Healthcare Group plc |
Tel: +44 (0)330 175 0000 |
|||
| Raffi Stepanian, Chief Executive Officer Alan Olby, Chief Financial Officer |
|
|||
| |
|
|||
| Panmure Liberum (Nominated Adviser & Broker) |
Tel: +44 (0)20 3100 2000 |
|||
| Will Goode Emma Earl Mark Rogers |
|
|||
|
|
|
|||
| Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or [email protected] |
|||
| Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
|||
| Rachel Broad |
Mob: +44 (0) 7747 515 393 |
|||
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com